Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study. (linkinghub.elsevier.com)

Authors: Nikolcheva T … Bonni A Journal: The Lancet Published: 2026-05-30 DOI: https://doi.org/10.1016/S0140-6736(26)00865-2